G6 confirms that since it announced a delay of its Annual Filings on September 29, 2022 (the “Filings Notice”) there is no material change to the information set out in the Filings Notice that has not been generally disclosed and there has been no failure by the Company in fulfilling its stated intentions with respect to satisfying the provisions of the alternative information guidelines set out in NP 12-203.
In response to the Annual Filings delay, the Company has applied for and been granted a management cease trade order (“MCTO”) under National Policy 12-203 – Management Cease Trade Orders (“NP 12-203”).
…is pleased to announce the expansion of its executive leadership and operations team to support the Company in its next phase of growth.
…is pleased to announce the launch of its redesigned website at www.Graphene-Supermarket.com. The redesigned website features an updated visual identity, along with an improved user interface and more streamlined and accessible website design experience for customers.
…is pleased to announce that its wholly owned subsidiary, Graphene Laboratories, Inc. (“GLI”), has recently received ISO 9001 certification (“ISO 9001”) for its manufacturing facility in Ronkonkoma, New York.
…is pleased to announce that its wholly owned subsidiary, Graphene Laboratories, Inc. (“GLI”), has recently received ISO 9001 certification (“ISO 9001”) for its manufacturing facility in Ronkonkoma, New York.
…has successfully installed and commenced the use of a new pilot-scale graphene oxide reactor (the “New Reactor”) at its facility in Ronkonkoma, New York. The New Reactor significantly increases the Company’s graphene oxide production capacity five-fold.
today announced the results of the
antimicrobial efficacy test on a prototype of G6’s proprietary graphene-based air purifier (the
“Lab Test”) conducted by a US-based microbiological laboratory of The Intertek Group plc. The
test showed that the concentration of pathogenic microorganisms present in the testing chamber
was reduced by 99.9% (“Test Results”) over the duration of the experiment.
today announced the closing of the previously announced acquisition of all membership interests (the “Transaction”) of GX Technologies, LLC (“GX Technologies” or “GX”), effective August 25, 2021 (the “Closing Date”).
is pleased to announce that it has executed a definitive purchase agreement (the “Agreement”) to formalize and close the previously announced acquisition (the “Transaction”) of all membership interests of GX Technologies, LLC (“GX Technologies”). Pursuant to the terms of the Agreement, the consideration paid for the membership interests of GX Technologies is 25,000,000 common shares (the “Consideration Shares”) of G6 at a deemed price of C$0.20 per common share of the Company.
is pleased to announce that Dr. Elena Polyakova, the Chief Executive Officer of the Company’s wholly-owned subsidiary, Graphene Laboratories Inc., NY, USA (“GLI”) since 2009, will be a keynote presenter addressing the attendees of the Graphene Korea 2021 International Conference (the “Conference”) taking place as a virtual event from May 26-28, 2021.
a technology company creating value through the development of innovative graphene-based solutions is pleased to announce that it has closed its non-brokered equity financing previously announced on March 15, 2021 (the “Offering”). Pursuant to the
Offering, G6 issued 27,071,000 units for gross proceeds of $5,414,200, which was increased due to strong
investor demand from an initial target of $5,000,000. Each unit was priced at $0.20 and was comprised of one common share of the Company and one-half of one warrant to purchase a common share of the Company at a price of $0.30 for a period of 2 years from the closing date of the Offering.
… is pleased to announce that it has entered into a letter agreement today, March 15, 2021, (the “LOI”) pursuant to which it intends to acquire all of the issued and outstanding shares of GX Technologies, Inc. (“GX Technologies”, the “Vendor”), in exchange for 25,000,000 common shares (the “Consideration Shares”) of G6 at a deemed price of $0.20 per common share of the Company (the “Transaction”). Simultaneously, the Company is pleased to announce a non-brokered equity financing to raise up to $5,000,000 through the offering of 25,000,000 units (the “Offering”). Each unit is priced at $0.20 and is comprised of one common share of the Company and one-half of one warrant to purchase a common share of the Company at a price of $0.30 for a period of 2 years from the closing date of the Offering.
